QuidelOrtho launches Certified Analyzer Program
Initiative to expand testing access to underserved U.S. communities
Initiative to expand testing access to underserved U.S. communities
The launch marks the highlight of a 10-year journey
Researchers receive funding to explore how fluorescent materials can detect the presence of pesticides and herbicides in food production
AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease
Direct, high-resolution imaging of cells on membrane inserts without removal or disruption
Enhance sample traceability, streamline inventory, and support compliance with a trusted, user-friendly LIMS solution
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Smarter packaging designed with customer needs in mind
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end
Elecsys pTau181 is the first in vitro diagnostic regulation (IVDR)-certified test to rule out Alzheimer’s associated amyloid pathology
Designed for use in decentralized, CLIA-waived settings, the test has been analytically verified in a study to deliver results comparable to standard laboratory methods
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space
The Runge mikron 91 inline pH probe is a full-fledged liquid chromatography detector squeezed into a tiny format
The new software is offered as a free upgrade for existing customers
New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results
Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing